Home / Stocks / ARWR

ARWR insider trading

ARROWHEAD PHARMACEUTICALS, INC. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
1
Bought · 24 mo
$62k
Buys · last 90 days
0 · $0
Most recent buy
2024-11-15

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-20PERRY MICHAEL S
Director
Sold11,600$87.30$1.0M
2025-12-30Anzalone Christopher Richard
Chief Executive Officer
Sold51,726$69.13$3.6M
2025-12-19Anzalone Christopher Richard
Chief Executive Officer
Sold82,037$63.97$5.2M
2025-12-16Anzalone Christopher Richard
Chief Executive Officer
Sold121,853$68.78$8.4M
2025-03-05Anzalone Christopher Richard
Chief Executive Officer
Sold300,000$17.58$5.3M
2024-11-15Lu Hongbo
Director
Bought2,400$25.91$62k

Most active insider buyers

InsiderRoleBuysTotal bought
Lu HongboDirector1$62k

See ARWR on the chart

Every insider buy and sell for ARWR plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.